Evidence map›Paper›PMID 23402792›Full record

ArticleCytokine2013

Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.

M A Llamas-Covarrubias, Y Valle, R Bucala, R E Navarro-Hernández, C A Palafox-Sánchez, J R Padilla-Gutiérrez, I Parra-Rojas, A G Bernard-Medina, Z Reyes-Castillo, J F Muñoz-Valle

Abstract read
In one paragraph

Article in Cytokine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 4 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 4 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Observational
  7. Distinctive Macrophage Migration Inhibitory Factor Receptor Patterns and Soluble Biomarkers in Rheumatoid Arthritis: Unveiling Key Associations with Disease Activity.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2025
    Article
  8. MIF contribution to progressive brain diseases.Journal of neuroinflammation · 2024
    Review
  9. Haplotypes of [-794(CATT)Molecular genetics & genomic medicine · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

M A Llamas-CovarrubiasFunctional Immunogenetics Group and PhD Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
Y Valle
R Bucala
R E Navarro-Hernández
C A Palafox-Sánchez
J R Padilla-Gutiérrez
I Parra-Rojas
A G Bernard-Medina
Z Reyes-Castillo
J F Muñoz-Valle
Universidad de Guadalajara · MXHospital Civil de Guadalajara · MXUniversidad Autónoma de Guerrero · MXYale University · US

Funding

Mechanisms of Rheumatoid Synovial Fibroblast ActivationR01AR049610 · NIAMS · YALE UNIVERSITY · PI BUCALA, RICHARD J · 2002 to 2018
$5.0M
INNATE AND ADAPTIVE MECHANISMS IN ARTHRITISR01AR050498 · NIAMS · YALE UNIVERSITY · PI BUCALA, RICHARD J · 2004 to 2013
$3.6M
NIAMS NIH HHS R01 AR049610NIAMS NIH HHS R01 AR050498
6 · The paper itself

Abstract

Macrophage migration inhibitory factor (MIF) is an upstream pro-inflammatory cytokine that is associated with the pathogenesis of autoimmune inflammatory diseases including rheumatoid arthritis (RA). Two polymorphisms in the upstream region exist in the MIF gene and are associated with RA susceptibility or severity in different populations. In this case-control study, we investigated whether MIF polymorphisms are associated with RA susceptibility or activity in a western Mexican population .The relationship of MIF levels with clinical features of disease also was assessed. Genotyping of the -794 CATT5-8 (rs5844572) and the -173 G>C (rs755622) polymorphisms was performed by PCR and PCR-RFLP respectively on 226 RA patients and 210 healthy subjects. Serum MIF levels were determined by ELISA. We found a significant association between the -794 CATT5-8 6,7 MIF genotype with RA. Moreover, we detected an association between the -794 CATT7 allele with early onset RA. The -794 CATT7 and -173(*)C alleles, which are in linkage disequilibrium, were associated with high disease activity on RA patients. A positive correlation between circulating MIF levels and C-reactive protein, erythrocyte sedimentation rate, rheumatoid factor, anti-citrullinated protein/peptides antibodies and TNFα was detected. MIF levels appear to be associated with disease progression rather than disease activity, which is distinct from the established relationship between disease activity and TNFα levels. In conclusion, the MIF gene and protein are associated with RA in a western Mexican population, with a main contribution onto early onset and early stages of disease.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdolescentAdultAgedAged, 80 and overAge of OnsetArthritis, RheumatoidCase-Control StudiesFemaleGene FrequencyHaplotypesHumansIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMaleIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID23402792
PMCPMC3683988
OpenAlexW2034210715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.